Hepatic Cystadenomas Treatment & Management
- Author: Krishan Ariyarathna, MD; Chief Editor: BS Anand, MD more...
No medical treatment has been found to be effective for management of hepatic cystadenomas.
Discontinuing hormonal treatment until the estrogen/progesterone receptor studies are completed is prudent.
Consult with the following specialists for treatment recommendations and procedures in patients with hepatic cystadenomas:
Dietary and activity considerations
No specific diet is recommended. In the presence of biliary obstruction, deficiency of fat-soluble vitamins should be corrected.
Activity is usually not restricted. However, after surgical intervention, standard precautions as in other abdominal surgery should be taken.
The treatment of choice for hepatic cystadenomas is surgical resection. Complete resection of the tumor is imperative to avoid local recurrence and malignant transformation. Note the following:
A complete lobectomy is sometimes necessary for larger lesions or in the presence of adenocarcinoma.
For smaller lesions, enucleation alone can usually be accomplished with preservation of the remaining hepatic parenchyma unless the tumor is in a central location close to the hepatic hilum. Enucleation is possible because cystadenomas have a thick fibrous capsule that can be dissected bluntly without major bleeding or biliary leak.
Surgical mortality is not higher than mortality associated with a corresponding hepatic resection or lobectomy.
Liver transplantation may be necessary in the rare occurrence of extensive bilobar extension of the tumor.
In a study of 51 patients, Gamblin et al investigated the efficacy of laparoscopic resection of symptomatic hepatic cysts. According to histologic examination, 90% of the lesions in the study were simple cysts, and 10% were cystadenomas. All patients who were operated on for pain experienced symptom relief. According to the authors, the study's results support a routine laparoscopic approach to the treatment of benign symptomatic cysts. They concluded that traditional surgical measures should be reserved for cases of expected malignancy or for those in which laparoscopy is contraindicated or the cyst recurs following laparoscopic treatment.
Abu Hilal et al also concluded that the laparoscopic approach represents a safe option for the management of benign and indeterminate liver lesions, even when major hepatectomy is required.
No further outpatient care is indicated routinely after complete surgical resection. However, because local recurrence of a cystadenoma with progression to cellular atypia and, ultimately, carcinoma has been described, regular postoperative follow-up is indicated. Follow-up is conducted best by performing abdominal US or CT scan at 6-month intervals for the first postoperative year and then annually.
Ratti F, Ferla F, Paganelli M, Cipriani F, Aldrighetti L, Ferla G. Biliary cystadenoma: short- and long-term outcome after radical hepatic resection. Updates Surg. 2012 Mar. 64(1):13-8. [Medline].
Fukunaga N, Ishikawa M, Ishikura H, et al. Hepatobiliary cystadenoma exhibiting morphologic changes from simple hepatic cyst shown by 11-year follow up imagings. World J Surg Oncol. 2008 Dec 11. 6:129. [Medline]. [Full Text].
Choi HK, Lee JK, Lee KH, et al. Differential diagnosis for intrahepatic biliary cystadenoma and hepatic simple cyst: significance of cystic fluid analysis and radiologic findings. J Clin Gastroenterol. 2010 Apr. 44(4):289-93. [Medline].
Fuks D, Voitot H, Paradis V, et al. Intracystic concentrations of tumour markers for the diagnosis of cystic liver lesions. Br J Surg. 2014 Mar. 101(4):408-16. [Medline].
Xu HX, Lu MD, Liu LN, et al. Imaging features of intrahepatic biliary cystadenoma and cystadenocarcinoma on B-mode and contrast-enhanced ultrasound. Ultraschall Med. 2012 Dec. 33(7):E241-9. [Medline].
Gamblin TC, Holloway SE, Heckman JT, Geller DA. Laparoscopic resection of benign hepatic cysts: a new standard. J Am Coll Surg. 2008 Nov. 207(5):731-6. [Medline].
Abu Hilal M, Di Fabio F, Teng MJ, Godfrey DA, Primrose JN, Pearce NW. Surgical management of benign and indeterminate hepatic lesions in the era of laparoscopic liver surgery. Dig Surg. 2011. 28(3):232-6. [Medline].
Abdul-Al HM, Makhlouf HR, Goodman ZD. Expression of estrogen and progesterone receptors and inhibin-alpha in hepatobiliary cystadenoma: an immunohistochemical study. Virchows Arch. 2007 Jun. 450(6):691-7. [Medline].
Baudin G, Novellas S, Buratti MS, et al. Atypical MRI features of a biliary cystadenoma revealed by jaundice. Clin Imaging. 2006 Nov-Dec. 30(6):413-5. [Medline].
Catinis GE, Frey DJ, Skinner JW, Balart LA. Hepatic cystadenoma: an unusual presentation. Am J Gastroenterol. 1998 May. 93(5):827-9. [Medline].
D'Errico A, Deleonardi G, Fiorentino M, Scoazec JY, Grigioni WF. Diagnostic implications of albumin messenger RNA detection and cytokeratin pattern in benign hepatic lesions and biliary cystadenocarcinoma. Diagn Mol Pathol. 1998 Dec. 7(6):289-94. [Medline].
Dardik H, Glotzer P, Silver C. Congenital hepatic cyst causing jaundice: report of a case and analogies with respiratory malformation. Ann Surg. 1964 Apr. 159:585-92. [Medline].
Franko J, Nussbaum ML, Morris JB. Choledochal cyst cholangiocarcinoma arising from adenoma: case report and a review of the literature. Curr Surg. 2006 Jul-Aug. 63(4):281-4. [Medline].
Grayson W, Teare J, Myburgh JA, Paterson AC. Immunohistochemical demonstration of progesterone receptor in hepatobiliary cystadenoma with mesenchymal stroma. Histopathology. 1996 Nov. 29(5):461-3. [Medline].
Horsmans Y, Laka A, Gigot JF, Geubel AP. Serum and cystic fluid CA 19-9 determinations as a diagnostic help in liver cysts of uncertain nature. Liver. 1996 Aug. 16(4):255-7. [Medline].
Ishak KG, Willis GW, Cummins SD, Bullock AA. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer. 1977 Jan. 39(1):322-38. [Medline].
Jenkins RL, Johnson LB, Lewis WD. Surgical approach to benign liver tumors. Semin Liver Dis. 1994 May. 14(2):178-89. [Medline].
Kanamori H, Kawahara H, Oh S, et al. A case of biliary cystadenocarcinoma with recurrent jaundice. Diagnostic evaluation of computed tomography. Cancer. 1985 Jun 1. 55(11):2722-4. [Medline].
Karahan OI, Kahriman G, Soyuer I, Ok E. Hepatic von Meyenburg complex simulating biliary cystadenocarcinoma. Clin Imaging. 2007 Jan-Feb. 31(1):50-3. [Medline].
Koffron A, Rao S, Ferrario M, Abecassis M. Intrahepatic biliary cystadenoma: role of cyst fluid analysis and surgical management in the laparoscopic era. Surgery. 2004 Oct. 136(4):926-36. [Medline].
Mills GC, Alperin JB, Trimmer KB. Studies on variant glucose-6-phosphate dehydrogenases: G6PD Fort Worth. Biochem Med. 1975 Jul. 13(3):264-75. [Medline].
Ramacciato G, Nigri GR, D'Angelo F, et al. Emergency laparotomy for misdiagnosed biliary cystadenoma originating from caudate lobe. World J Surg Oncol. 2006 Nov 7. 4:76. [Medline].
Sanchez H, Gagner M, Rossi RL, et al. Surgical management of nonparasitic cystic liver disease. Am J Surg. 1991 Jan. 161(1):113-8; discussion 118-9. [Medline].
Shimada M, Takenaka K, Gion T, et al. Treatment strategy for patients with cystic lesions mimicking a liver tumor: a recent 10-year surgical experience in Japan. Arch Surg. 1998 Jun. 133(6):643-6. [Medline].
Teoh AY, Ng SS, Lee KF, Lai PB. Biliary cystadenoma and other complicated cystic lesions of the liver: diagnostic and therapeutic challenges. World J Surg. 2006 Aug. 30(8):1560-6. [Medline].
Terada T, Kitamura Y, Ohta T. Endocrine cells in hepatobiliary cystadenomas and cystadenocarcinomas. Virchows Arch. 1997 Jan. 430(1):37-40. [Medline].
Wheeler DA, Edmondson HA. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer. 1985 Sep 15. 56(6):1434-45. [Medline].
Woods GL. Biliary cystadenocarcinoma: Case report of hepatic malignancy originating in benign cystadenoma. Cancer. 1981 Jun 15. 47(12):2936-40. [Medline].